Leveraging the Power and Promise of Aptamers to Deliver Improved Medicines for Unmet Medical NeedsArchemix has a fully integrated R&D organization with internal capabilities in activities ranging from aptamer discovery through clinical development. We have the experience, skills and infrastructure to take programs from target nomination to product registration. The unique strengths that differentiate Archemix from other biotechnology companies are in the following areas:
|
"I've been intrigued by SELEX ever since the first aptamer papers came out, so I jumped at the opportunity to join Archemix when the company was founded. Our team has taken aptamer technology to the next level by developing powerful medicinal chemistry techniques as well as expanding the repertoire of SELEX methods and viable pool compositions. I have enormous confidence in the ability of Archemix scientists to turn aptamers into drugs." – Sharon Cload, Senior Director, Aptamer Discovery |
|
Aptamer Discovery